News | April 19, 2026
Takara Bio and Resistomap forge deal to speed up global fight against superbugs
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
The product is manufactured at AKUMS’ state-of-the-art injectable facility in Kotdwar, Uttarakhand
EBITDA for Q1 FY25 is at Rs. 100 crore compared to Rs. 32 crore in the previous year
Collaboration provides AstraZeneca with exclusive rights to Omniose’s proprietary bioconjugation platform to explore potential vaccines for a broad range of bacterial pathogens
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
Subscribe To Our Newsletter & Stay Updated
